Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Read This Quickly, It Will Probably Be Taken Down

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155179
(Total Views: 756)
Posted On: 12/28/2021 8:54:09 PM
Posted By: calstang
Read This Quickly, It Will Probably Be Taken Down After A Couple of Minutes...
(Rand Paul Is "Calling Out" Dr Fauci)

We must protect the sacred stringent protocol of the drug approval process="BS"
"If a drug is safe and may provide benefit"?????
"p value will not be more important than human life"????
CD16, CD17, CD18, CD19, CD20 Brazil, 2 years later now USA????
Give me some common sense, some integrity and some moxy to get the "right thing" done.
No words can describe how terrible and corrupt and evil certain power players have been. Thousands and thousands of dead people, should be alive today. The corruption is stunningly shocking, as evil as any eviil ever displayed on planet earth. Since April of 2020, it has been known that Leronlimab cures a high percentage of patients with covid19, when Dr Bruce Patterson spoke at "Ted Talks" describing Leronlimab as the solution to this virus. The FDA "restricted" Leronlimab to only being given twice durig CD12, after Dr Patterson had revealed that during the extremely successful eIND treatments, they gave Leronlimab to patients 3 or 4 times, up to about day 28. This single control, resulted in the Primary Endpoint being missed in CD12, no EUA for Leronlimab, and massive deaths for mankind. So the FDA must protect itself from this crime, and writes a derogatory letter, telling the world that there is not sufficient data to support the approval nor use of Leronlimab for covid19 patients. Still today, no Leronlimab, no efficacious covid19 therapeutic for severe or critical patients, deaths per day from covid19 have returned to near all time highs, and Leronlimab vials sit on shelves gathering dust. Shame on us, shame on our government, shame on our FDA. The evil inside man is frightening, once again.


(11)
(1)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us